NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/26/2025
Back to search
Official data from USPTO
PHEBRA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
09/27/2025
Trademark type
Word
Nice classes
5
Filing date
07/19/2018
Registration date
07/30/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/26/2025
Last transaction
09/27/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
New South Wales, AU
Examiner
EULIN,INGRID C
Current location
Historical data usage
Holders and representatives
Holders
Phebra Pty Ltd
Phebra Pty Ltd
Representatives
Amber M. Underhill Warner Norcross + Judd LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of paincancerinfectious diseasesgastrointestinal diseases and conditionsskin conditionsrespiratory conditionsneurological disorderspsychiatric disordersgenetic disordershormonal disorderscardiovascular disordershuman ion imbalances; cardiovascular agents for medical purposes; medicines for human purposesmedicines for the treatment of cancerepilepsy and manicdepressive and psychotic states; medicinal preparationsmedicines for the treatment of cancerepilepsy and manicdepressive and psychotic states; vitamin preparations; electrolyte solutions for medical useelectrolyte replacement solutions ; vaccines; antidotes; diagnostic agents for pharmaceutical use; diagnostic preparations for medical purposes; in-vivo diagnostic agents used to visualize and differentiate tissues in the bodyto monitor the functioning and patency of tissues and organs; injectable solutions for medical purposessterile injectable dyes for in vivo human medical diagnostic procedures
Publications
History of USPTO decisions and trademark events.
27 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/26/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/26/2025
E815
TEAS SECTION 8 & 15 RECEIVED
05/16/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/30/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/14/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/14/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/14/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/14/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/14/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/14/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
07/30/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/14/2019
PUBO
PUBLISHED FOR OPPOSITION
05/14/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/24/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/05/2019
ALIE
ASSIGNED TO LIE
04/05/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/14/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/22/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/21/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/21/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/09/2018
GNRT
NON-FINAL ACTION E-MAILED
11/09/2018
CNRT
NON-FINAL ACTION WRITTEN
11/09/2018
DOCK
ASSIGNED TO EXAMINER
11/07/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/24/2018
NWAP
NEW APPLICATION ENTERED
07/23/2018
Continuous trademark protection
Get notified about every new filing that threatens PHEBRA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.